Balance Sheet - Immuneering Corp (IMRX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 172.83 | -36,072.43 | 85.67 | 105.52 | 149.20 | 37.09 | 13.78 |
| Accounts receivable, net | 0.00 | 0.01 | 0.25 | 0.50 | 0.21 | ||
| Inventories | 0.00 | -74.31 | |||||
| Other current assets | 3.41 | 3.44 | 3.42 | 3.21 | 2.89 | 0.14 | 0.07 |
| Total current assets | 176.25 | 39.59 | 89.08 | 108.75 | 152.33 | 37.73 | 14.06 |
| Total non-current assets | 55.74 | 13.13 | 13.50 | 13.62 | 14.37 | 0.69 | 0.04 |
| Total assets | 231.99 | 52.71 | 102.58 | 122.37 | 166.70 | 38.42 | 14.10 |
| Total current liabilities | 10.07 | 7.50 | 7.85 | 8.05 | 5.63 | 2.26 | 0.51 |
| Total non-current liabilities | 3.43 | 3.82 | 4.16 | 4.46 | 5.09 | 58.65 | 20.12 |
| Total liabilities | 13.50 | 11.33 | 12.01 | 12.52 | 10.72 | 60.90 | 20.63 |
| Total stockholders' equity | 218.48 | 41.39 | 90.58 | 109.85 | 155.98 | -22.48 | -6.53 |
| Common shares outstanding | 44 | 30 | 28 | 26 | 26 | 14 | 14 |
Show Quarterly Balance Sheet
Balance Sheet - Immuneering Corp (IMRX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 156,693.62 | 172.83 | 227.56 | 26.36 | 35.87 | 36.14 | 50.66 | 59.73 | 71.28 | 85.67 | 97.24 | 108.99 | 91.54 | 105.52 | 117.20 | 128.10 | 137.77 | 149.20 | 149.48 | 50.25 | 30.93 | 37.09 | 0.00 | 0.00 | 13.78 |
| Accounts receivable, net | 0.00 | 0.00 | 0.74 | 0.00 | 0.01 | 0.07 | 0.18 | 0.28 | 0.25 | 0.47 | 0.50 | 0.49 | 0.50 | ||||||||||||
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||
| Other current assets | 4,715.54 | 3.41 | 1.54 | 1.37 | 2.34 | 3.44 | 4.60 | 3.96 | 3.17 | 3.42 | 3.34 | 2.52 | 2.70 | 3.21 | 2.76 | 0.89 | 1.48 | 2.89 | 3.36 | 0.70 | 0.76 | 0.14 | |||
| Total current assets | 161,409.16 | 176.25 | 229.10 | 27.73 | 38.21 | 39.59 | 55.26 | 63.69 | 74.45 | 89.08 | 100.58 | 111.51 | 94.23 | 108.75 | 120.02 | 129.17 | 139.53 | 152.33 | 153.31 | 51.44 | 32.18 | 37.73 | 13.78 | ||
| Total non-current assets | 53,400.63 | 55.74 | 11.95 | 12.33 | 12.48 | 13.13 | 13.30 | 13.40 | 13.54 | 13.50 | 13.30 | 13.39 | 13.46 | 13.62 | 13.67 | 12.88 | 12.92 | 14.37 | 10.73 | 1.61 | 0.67 | 0.69 | -13.78 | ||
| Total assets | 214,809.79 | 231.99 | 241.06 | 40.06 | 50.68 | 52.71 | 68.56 | 77.09 | 87.98 | 102.58 | 113.88 | 124.90 | 107.70 | 122.37 | 133.69 | 142.05 | 152.45 | 166.70 | 164.04 | 53.04 | 32.86 | 38.42 | |||
| Total current liabilities | 4,974.25 | 10.07 | 9.55 | 7.49 | 5.11 | 7.50 | 6.92 | 6.78 | 5.18 | 7.85 | 5.62 | 5.48 | 5.53 | 8.05 | 7.26 | 3.80 | 3.67 | 5.63 | 5.27 | 4.83 | 2.76 | 2.26 | |||
| Total non-current liabilities | 3,317.37 | 3.43 | 3.53 | 3.63 | 3.73 | 3.82 | 3.92 | 4.00 | 4.08 | 4.16 | 4.24 | 4.31 | 4.38 | 4.46 | 4.54 | 4.65 | 4.72 | 5.09 | 0.48 | 0.50 | 0.52 | 58.65 | |||
| Total liabilities | 8,291.62 | 13.50 | 13.08 | 11.12 | 8.84 | 11.33 | 10.84 | 10.78 | 9.26 | 12.01 | 9.86 | 9.79 | 9.91 | 12.52 | 11.80 | 8.46 | 8.39 | 10.72 | 5.75 | 5.34 | 3.28 | 60.90 | |||
| Total stockholders' equity | 206,518.17 | 218.48 | 227.98 | 28.94 | 41.84 | 41.39 | 57.72 | 66.31 | 78.72 | 90.58 | 104.02 | 115.10 | 97.79 | 109.85 | 121.89 | 133.59 | 144.06 | 155.98 | 158.29 | 47.71 | 29.57 | -22.48 | 10.08 | ||
| Common shares outstanding | 44 | 44 | 40 | 36 | 36 | 31 | 30 | 30 | 29 | 29 | 29 | 29 | 26 | 26 | 26 | 26 | 26 | 26 | 18 | 24 | 14 | 14 | 14 | 14 | 14 |